Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001415889-24-030159·Mersana Therapeutics, Inc.
Schedule 13G ownership disclosure
MERSANA THERAPEUTICS INC
Common Stock, $0.0001 par value per share · CUSIP: 59045L106
Event date: 2024-12-20
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Nextech Crossover I GP S.a. r.l.
Shares: 12,067,246.00 · Class: 10.4%
- Nextech Crossover I SCSp
Shares: 12,067,246.00 · Class: 10.4%
- Ian Charoub
Shares: 12,067,246.00 · Class: 10.4%
- Costas Constantinides
Shares: 12,067,246.00 · Class: 10.4%
- Rocco Sgobbo
Shares: 12,067,246.00 · Class: 10.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-24-030159
- Form type
- SCHEDULE 13G/A
- Filer
- Mersana Therapeutics, Inc.
- CIK
- CIK 1442836
- Filed
- Dec 26, 2024
- Reporting period
- Dec 20, 2024
- Description
- Schedule 13G beneficial ownership